Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Mar;9(3):186-188.
doi: 10.1016/S2468-1253(23)00451-X. Epub 2024 Jan 15.

The neoadjuvant approach in resectable pancreatic ductal adenocarcinoma: lessons learned

David Henault  1 , C Benedikt Westphalen  2 , Grainne M O'Kane  3
Affiliations
Comment

The neoadjuvant approach in resectable pancreatic ductal adenocarcinoma: lessons learned

David Henault et al. Lancet Gastroenterol Hepatol. 2024 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

DH has received a personal salary grant from the Government of Quebec (Canada) to lead a post-doctoral fellowship. CBW has received grants from Roche; has received consulting fees, payment for lectures, and payment for expert testimony from Servier; and has also participated on a data safety monitoring board or advisory board for Servier. GMO'K has received grants from Roche and AstraZeneca; consulting fees from AstraZeneca, Servier, and Incyte; payment for lectures from Roche, and support for attending meetings from MSD and Roche.

Comment on

  • Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
    Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K; Nordic Pancreatic Cancer Trial-1 study group. Labori KJ, et al. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38237621 Clinical Trial.

References

MeSH terms

LinkOut - more resources